Mild-to-Moderate Asthma

Researchers are investigating a potential treatment for mild-to-moderate asthma. Thhis study aims to assess the treatment's safety, monitor any side effects, and measure how much of the treatment remains in the body over time.

Chest and lungs

Study Purpose/Description

This study is investigating a potential treatment for mild-to-moderate asthma. The trial aims to assess the treatment’s safety, monitor any side effects, and measure how much of the treatment remains in the body over time.

If you are interested in taking part in this study, you can complete a screening survey at this link.

What’s Involved?

If you are eligible for the trial, you will be randomly assigned to receive either the study drug, or a placebo. Neither you, the other participants, nor the clinical staff will know which treatment you are receiving.

During the trial the potential treatment will be administered via injection, with two doses given four weeks apart, and during this period you will have scheduled visits to the clinic to monitor your health and gather important data for evaluating the treatment’s safety.

Procedures

Physical examination
Vital signs
Blood samples
ECG
Questionnaires and assessments
Urine Pregnancy Test
Administration of investigational treatment

If accepted into the study, as payment for your time, out of pocket expenses and inconvenience experienced, you will receive up to $7,300 for completing the study.

If you are interested in taking part in this study, you can complete a screening survey at this link.

Recruitment criteria

You may be eligible to participate in this study if you:

are aged between 18 and 65 years old
weigh less than 120kg
were diagnosed with asthma by a physician at least 12 months ago
can commit to up to 15 clinic visits, including two four-night stays, at the Morayfield Clinic in Moreton Bay over a period of approximately 28 weeks.

Benefits

If accepted into the study, as payment for your time, out of pocket expenses and inconvenience experienced, you will receive up to $7,300 for completing the study.

Study sponsor / funder

Research team contacts

Research Team

[email protected]

07 5409 8640

The Join Us Register Acknowledges the Traditional Owners of the lands across Australia as the continuing custodians of Country and acknowledge the many Aboriginal and Torres Strait Islander people of this land. We pay our respect to First Nations peoples and Elders, past and present.

We acknowledge and celebrate the knowledge and the strengths of Aboriginal and Torres Strait Islander peoples and communities and recognise their continuing connection to land and waters.

We thank the many Aboriginal and Torres Strait Islander communities, and the many individuals, organisations that have supported and guided us through our journey.

There is a huge opportunity to partner more with Aboriginal and Torres Strait Islander communities to build on existing community strengths and resilience, often in the face of ongoing inequities. Through Join us, we will work together in the spirit of reciprocity to address ongoing impacts of colonisation so that we can all realise optimal health and wellbeing.

+ 61 2 8052 4300

[email protected]

Mild-to-Moderate Asthma

Study Purpose/Description

What’s Involved?

Recruitment criteria

Benefits

Study sponsor / funder

Research team contacts

Research Team

Join Us Register

For Participants

For Researchers

Resources

An initiative of

Register your interest